Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation

American Industrial Hygiene Association Journal

Volumn 57, Issue 1, 1996, Pages 23-32

  Thomas, Russell S ^a   Bigelow, Phillip L ^a   Keefe, Thomas J ^a   Yang, Raymond S H ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1 TRICHLOROETHANE; BENZENE; CARBON TETRACHLORIDE; CHLOROFORM; DICHLOROMETHANE; SOLVENT; TRICHLOROETHYLENE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; COMPUTER SIMULATION; FEMALE; HUMAN; HUMAN TISSUE; INDIVIDUALITY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; OCCUPATIONAL EXPOSURE; STATISTICAL MODEL; SYSTEM ANALYSIS;

EID: 0030069951     PISSN: 00028894     EISSN: None     Source Type: Journal    
DOI: 10.1080/15428119691015188     Document Type: Article

References (56)

1. Fiserova-Bergerova, V.: Development of biological exposure indices (BEIs) and their implementation. Appl. Ind. Hyg. 2(2):87-92 (1987).
2. Leung, H.W. and D.J. Paustenbach: Application of pharmacokinetics to derive biological exposure indexes from threshold limit values. Am. Ind. Hyg. Assoc. J. 49:445-450 (1988).
3. Hermann, E.R. and J.E. Peterson: Evaluation. In Fundamentals of Industrial Hygiene. B.A. Plog, ed. 3rd ed. Washington, DC: National Safety Council, 1988. pp. 387-396.
4. Perbellini, L., P. Mozzo, D. Olivato, and F. Brugnone: "Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model. Am. Ind. Hyg. Assoc. J. 51:356-362 (1990).
5. Leung, H.W.: Use of physiologically based pharmacokinetic models to establish biological exposure indexes. Am. Ind. Hyg. Assoc. J. 53:369-374 (1992).
6. Fiserova-Bergerova, V., J. Vlach, and J.C. Cassady: Predictable "individual differences" in uptake and excretion of gases and lipid soluble vapours simulation study. Brit. J. Ind. Med. 37:42-49 (1980).
7. Droz, P.O., M.M. Wu, W.G. Cumberland, and M. Berode: Variability in biological monitoring of solvent exposure: I. Development of a population physiological model. Brit. J. Ind. Med. 46:447-460 (1989).
8. Droz, P.O., M.M. Wu, and W.G. Cumberland: Variability in biological monitoring of organic solvent exposure: II. Application of a population physiological model. Brit. J. Ind. Med. 46:547-558 (1989).
9. Yang R.S.H. and M.E. Andersen: Pharmacokinetics. In Introduction to Biochemical Toxicology. E. Hodgson and P.E. Levi, eds. 2nd ed. Norwalk, CT: Appleton and Lange, 1994. pp. 49-73.
10. El-Masri, H.A., R.S. Thomas, S.A. Benjamin, and R.S.H. Yang: Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment. Toxicol. (1995) [In press]
11. American Conference of Governmental Industrial Hygienists (ACGIH): Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices for 1994-1995. Cincinnati, OH: ACGIH, 1994.
12. Ramsey, J.C. and M.E. Andersen: A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:159-175 (1984).
13. Gargas, M.L., M.E. Andersen, and H.J. Clewell: A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 86:341-352 (1986).
14. Lindstedt, S.: "Calculation of allometric scaling factors within and among species." May 25, 1994. [Private communication] Dr. Stan Lindstedt, Design Physiology and Functional Morphology Group, Department of Biological Sciences, Northern Arizona University, Flagstaff, AZ 86011-5640.
15. Altman, P.L., J.F. Gibson, and C.C. Wang: Effects of exercise. In Handbook of Respiration. D.S. Dittmer and R.M. Grebe, eds. Philadelphia, PA: W.B. Saunders Company, 1958. p. 143.
16. Chapman, C.B. and R.S. Fraser: Studies on the effect of exercise on cardiovascular function: cardiac output and mean circulation time. Circulation 9:57-62 (1954).
17. Mitchell, J.H., B.J. Sproule, and C.B. Chapman: The physiological meaning of the maximal oxygen intake test. J. Clin. Invest. 37:538-547 (1958).
18. McMichael, J. and E.A. Johnston: Postural changes in cardiac output and respiration in man. Quart. J. Exp. Physiol. 27:55-72 (1937).
19. Holmgren, A., B. Jonsson, and T. Sjostrand: Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities. Acta Physiol. Scand. 49:343-363 (1960).
20. Lundbergh, P. and T. Strandell: Hepatic wash-out curves of Kr-85 and Xe-133 after retrograde hepatic venous injections in patients with infectious hepatitis and in controls. Scand. J. Clin. Lab. Invest. 35:277-285 (1974).
21. Sherriff, S.B., R.C. Smart, and I. Taylor: Clinical study of liver blood flow in man measured by Xe-133 clearance after portal vein injection. Gut 18:1027-1031 (1977).
22. Munck, O. and N.A. Lassen: Bilateral cerebral blood flow and oxygen consumption in man by use of Kr-85. Circ. Res. 5:163-168 (1957).
23. Smith, H.W.: The Kidney: Structure and Function in Health and Disease. New York: Oxford University Press, 1951.
24. Grimby, G., E. Haggendal, and B. Saltin: Local xenon 133 clearance from the quadriceps muscle during exercise in man. J. Appl. Physiol. 22(2):305-310 (1967).
25. Sejrsen, J.: Blood flow in cutaneous tissue in man studied by washout of radioactive xenon. Circ. Res. 25:215-229 (1969).
26. Lesser, G.T. and S. Deutsch: Measurement of adipose tissue blood flow and perfusion in man by uptake of Kr-85. J. Appl. Physiol. 23(5):621-630 (1967).
27. Steiner, E.H.: Planning and analysis of results of collaborative tests. In Statistical Manual of the Association of Official Analytical Chemists. Washington, DC: Association of Official Analytical Chemists, 1975. pp. 66-88.
28. Vander, A.J., J.H. Sherman, and D.S. Luciano: Human Physiology: The Mechanisms of Body Function. 6th ed. New York: McGraw-Hill, 1994.
29. Frisancho, A.R.: New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am. J. Clin. Nutr. 40:808-819 (1984).
30. Boyd, E.: Normal variability in weight of the adult human liver and spleen. Arch. Pathol. 16:350-372 (1993).
31. Weibel, E.R.: Morphometry of the Human Lung. Berlin: Springer-Verlag, 1963.
32. International Commission on Radiological Protection: Report of the Task Group on Reference Man, (No. 23). New York: Pergamon Press, 1975.
33. Womersley, J., J.V.G.A. Durnin, K. Boddy, and M. Mahaffy: Influence of muscular development, obesity, and age on the fat-tree mass of adults. J. Appl. Physiol. 41(2):223-229 (1976).
34. Peter, R., R. Bocker, P.H. Beaune, M. Iwasaki, et al.: Hydroxylation of chlorzoxazone as a specific probe for liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3:566-573 (1990).
35. Reitz, R.H., A.L. Mendrala, and F.P. Guengerich: In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97:230-246 (1989).
36. Datta, D.V., S. Singh, A.K.S. Samanta, S. Saha, et al.: Determination of bromsulphthalein-glutathione conjugating enzyme activity in needle biopsy specimens of human liver. Clin. Chem. Acta 47:133-137 (1973).
37. Hunter, J., J.D. Maxwell, D.A. Stewart, and R. Williams: Increased hepatic microsomal enzyme activity from occupational exposure to certain organochlorine pesticides. Nature 237:399-401 (1972).
38. Araki, S.: Effects of urinary volume on urinary concentrations of lead, δ-aminolaevulinic acid, coproporphyrin, creatinine, and total solutes. Brit. J. Ind. Med. 37:50-54 (1980).
39. Johansson, I. and M. Ingelman-Sundberg: Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 IIEI in rat and rabbit liver microsomes. Cancer Res. 48:5387-5390 (1988).
40. Guengerich, F.P., D.H. Kim, and M. Iwasaki: Role of human cytochrome P-450 IIEI in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168-179 (1991).
41. Raucy, J.L., J.C. Kraner, and J.M. Lasker: Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23(1):1-20 (1993).
42. Wrighton, S.A. and J.C. Stevens: The human hepatic cytochromes p450 involved in drug metabolism. Crit. Rev. Toxicol. 22(1):1-21 (1992).
43. Andersen, M.E., H.J. Clewell, M.L. Gargas, F.A. Smith, et al.: Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:185-205 (1987).
44. van Haaften, A.B. and S.T. Sie: The measurement of phenol in urine by gas chromatography as a check on benzene exposure. Am. Ind. Hyg. Assoc. J. 26:52-58 (1965).
45. Gargas, M.L., R.J. Burgess, D.E. Voisard, G.H. Cason, et al.: Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99 (1989).
46. Gargas, M.L.: "Variability in partition coefficients of selected organic compounds." October 21, 1994. [Private communication] Dr. Michael Gargas, McLaren/Hart/ChemRisk, Courtland East Building, 29225 Chagrin Blvd., Cleveland, OH 44122-4629.
47. Portier, C.J. and N.L. Kaplan: Variability of safe dose estimates when using complicated models of the carcinogenic process. Fund. Appl. Toxicol. 13:533-544 (1989).
48. Naylor, T., J. Balinty, D. Burdick, and K. Chu: Computer Simulation Techniques. New York: John Wiley & Sons, 1968.
49. Filliben, J.J.: The probability plot correlation coefficient test for normality. Technometrics 17(1):111-117 (1975).
50. American Conference of Governmental Industrial Hygienists (ACGIH): Documentation of the biological exposure indices. In Documentation of the Threshold Limit Values and Biological Exposure Indices, vol. 3, 6th ed. Cincinnati, OH: ACGIH, 1991.
51. McDougal, J.N., G.W. Jepson, H.J. Clewell, M.G. MacNaughton, et al.: A physiological pharmacokinetic model for dermal absorption of vapors in the rat. Toxicol. Appl. Pharmacol. 85:286-294 (1986).
52. McDougal, J.N., G.W. Jepson, H.J. Clewell, M.L. Gargas, et al.: Dermal absorption of organic chemical vapors in rats and humans. Fund. Appl. Toxicol. 14:299-308 (1990).
53. Andersen, M.E. and H.J. Clewell: "Pharmacokinetic interactions of mixtures." Paper presented at 14th Conference on Environmental Toxicology. (AFAMRL-TR-83-099). Air Force Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH. 1984.
54. Mumtaz, M.M., I.G. Sipes, H.J. Clewell, and R.S.H. Yang: Risk assessment of chemical mixtures: biologic and toxicologic issues. Fund. Appl. Toxicol. 21:258-269 (1993).
55. Curtis, L.R., W.L. Williams, and H.M. Mehendale: Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (kepone) in the male rat. Toxicol. Appl. Pharmacol. 51:283-293 (1979).
56. Mehendale, H.M.: Mechanism of the interactive amplification of halomethane hepatotoxicity and lethality by other chemicals. In Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches. R.S.H. Yang, ed. San Diego, CA: Academic Press, 1994. pp. 299-334.